Site-Overview.com
 

Websites using electronic treatment administration record as a keyword

Here you can see a list of websites which are using electronic treatment administration record as keyword according to our database.

 
Websites found: 50
Number of websited displayed: 50
 

Queries in the same category:

 

List of results:

INGREZZA® (valbenazine) for adults with tardive dyskinesia (TD)
http://site-overview.com/stats/ingrezza.com
Learn more about INGREZZA—the first FDA-approved treatment for adults with tardive dyskinesia (TD).
  • Google Analytics ID: 76386630-3
  • Website Address renewal date: 17/10/15
  • Domain Address Reg. date: 15/12/14
  • Website address in use until: 18/12/14
Home | SITS International
http://site-overview.com/stats/sitsinternational.org
SITS (Safe Implementation of Treatment in Stroke) is a non-profit, research-driven, independent, international collaboration, with its base at the Karolinska Institute in Sweden. SITS is an initiative by the medical profession to provide safe implementation of stroke treatment in routine clinical practice. SITS vision is to reduce the global burden of stroke; by improving the stroke outcome, preventing recurrent stroke and find the best treatments. This will help the authorities to monitor new treatments and set new guidelines. This will also increase the quality of life for stroke patients and save lives.
  • Google Analytics ID: 76122842-1
  • Website Address renewal date: 18/1/11
  • Domain Address Reg. date: 09/2/9
  • Website address in use until: 19/2/9
Type 2 Diabetes Medication | BYETTA® (exenatide) injection
http://site-overview.com/stats/byetta.com
BYETTA is a non-insulin type 2 diabetes injection medication for adults.
  • Website Address renewal date: 17/1/29
  • Domain Address Reg. date: 04/2/3
  • Website address in use until: 18/2/3
SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol For Health Care Professionals
http://site-overview.com/stats/symbicorttouchpoints.com
Official HCP site for SYMBICORT, an asthma and COPD treatment, providing information on the inhaler, side effects, dosage and prescribing information.
  • Website Address renewal date: 16/10/11
  • Domain Address Reg. date: 09/10/15
  • Website address in use until: 17/10/15
MOVANTIK® (naloxegol) | Mu-Opioid Receptor Antagonist
http://site-overview.com/stats/movantikhcp.com
Official health care professional Web site for MOVANTIK® (naloxegol) tablets, for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.
  • Website Address renewal date: 16/1/29
  • Domain Address Reg. date: 14/2/14
  • Website address in use until: 19/2/14
Wallace Group - Engineering and Design
http://site-overview.com/stats/wallacegroup.us
Wallace Group is a reflection of our community. We are active volunteers and leaders in our business and personal communities and we have a commitment to the long-term health and viability of our built environment.
  • Google Analytics ID: 30247535-1
  • Website Address renewal date: 11/12/20
  • Domain Address Reg. date: 03/12/22
  • Website address in use until: 20/12/21
BOMAC
http://site-overview.com/stats/bomaccontractors.com
  • Website Address renewal date: 10/12/14
  • Domain Address Reg. date: 10/3/3
  • Website address in use until: 20/3/3
SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol | Asthma & COPD Medicine
http://site-overview.com/stats/mysymbicort.com
Official patient Web site for SYMBICORT, a medicine for the treatment of asthma and COPD. Find information about the inhaler and side effects
  • Website Address renewal date: 16/7/21
  • Domain Address Reg. date: 06/7/25
  • Website address in use until: 17/7/25
TRELSTAR® (triptorelin pamoate for injectable suspension) | Palliative Treatment for Advanced Prostate Cancer
http://site-overview.com/stats/trelstar.com
TRELSTAR® (triptorelin pamoate for injectable suspension) is a palliative treatment for men with advanced prostate cancer. View Important Safety Information and full Prescribing Information on website. Learn more about Trelstar®’s MOA, efficacy, dosing, and administration.
  • Website Address renewal date: 17/3/21
  • Domain Address Reg. date: 02/7/17
  • Website address in use until: 17/7/17
Welcome to TCB Caring Hands - TCB Caring Hands
http://site-overview.com/stats/tcbcaringhands.org
TCB caring hands--honoring all veterans
  • Website Address renewal date: 16/9/5
  • Domain Address Reg. date: 10/11/10
  • Website address in use until: 17/11/10
Bioforcetech Corporation - Biomass Management Systems
http://site-overview.com/stats/bioforcetech.com
BioForceTech was built to solve the problem of biosolids treatment. To achieve this goal, a team of experts in the fields of biotechnology, business administration, and energy, mechanical, and software engineering was formed.
  • Google Analytics ID: 48371208-7
  • Website Address renewal date: 16/6/22
  • Domain Address Reg. date: 12/6/21
  • Website address in use until: 18/6/21
Rosacea Treatment Options | Soolantra® Cream
http://site-overview.com/stats/soolantra.com
The active ingredient in Soolantra® (ivermectin) Cream, 1% is ivermectin, which is reported to have anti-parasitic and anti-inflammatory properties, however the exact mechanism of action of Soolantra Cream in the treatment of rosacea is unknown. Soolantra Cream treats the bumps and blemishes of rosacea with a once-daily, easy to apply cream.
  • Website Address renewal date: 17/2/19
  • Domain Address Reg. date: 13/3/19
  • Website address in use until: 18/3/19
COPD Treatment | TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder)
http://site-overview.com/stats/tudorza.com
Patient information on TUDORZA PRESSAIR (aclidinium bromide inhalation powder), an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with COPD.
  • Website Address renewal date: 16/3/31
  • Domain Address Reg. date: 11/3/4
  • Website address in use until: 20/3/4
Official Website for BYDUREON® (exenatide extended-release for injectable suspension)
http://site-overview.com/stats/bydureon.com
Learn about BYDUREON® (exenatide extended-release for injectable suspension), a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.
  • Website Address renewal date: 16/1/29
  • Domain Address Reg. date: 07/11/15
  • Website address in use until: 22/11/15
KOVALTRY®, Antihemophilic Factor (Recombinant)
http://site-overview.com/stats/kovaltry-us.com
Learn about KOVALTRY®, Antihemophilic Factor (Recombinant), including uses, safety, and administration information.
  • Website Address renewal date: 16/2/22
  • Domain Address Reg. date: 14/2/27
  • Website address in use until: 18/2/27
Asthma Treatment | PULMICORT FLEXHALER® (budesonide inhalation powder, 90 mcg & 180 mcg)
http://site-overview.com/stats/pulmicortflexhaler.com
Official patient site. Learn about PULMICORT FLEXHALER a medication for the maintenance treatment of asthma symptoms in adults and children 6 years or older. Find information about the inhaler and side effects and a How to Use FLEXHALER video.
  • Website Address renewal date: 16/11/12
  • Domain Address Reg. date: 06/11/16
  • Website address in use until: 17/11/16
Industrial Water Treatment Merus Ring - The Water Conditioning Company
http://site-overview.com/stats/merusonline.com
water treatment - solution to fight fouling, corrosion, rust, lime scale, biofouling and algae in cooling water, heat exchangers.
  • Google+ Identity: +Merusonline
  • Google Analytics ID: 163206-2
  • Website Address renewal date: 16/7/25
  • Domain Address Reg. date: 00/7/24
  • Website address in use until: 17/7/24
BRILINTA® (ticagrelor) tablets | Heart Attack Treatment
http://site-overview.com/stats/brilinta.com
Read about BRILINTA® (ticagrelor) tablets, a prescription medication for heart attack treatment, or severe chest pain, also known as unstable angina.
  • Website Address renewal date: 17/4/17
  • Domain Address Reg. date: 05/4/21
  • Website address in use until: 18/4/21
Nitolic® - Head Lice Treatment
http://site-overview.com/stats/nitolic.com
  • Website Address renewal date: 17/3/5
  • Domain Address Reg. date: 13/3/21
  • Website address in use until: 18/3/21
PULMICORT FLEXHALER® (budesonide inhalation powder, 90 mcg & 180 mcg)
http://site-overview.com/stats/pulmicortflexhalertouchpoints.com
Official health care professional website for PULMICORT FLEXHALER® (budesonide inhalation powder, 90 mcg & 180 mcg), a maintenance asthma treatment for patients 6 years of age and older.
  • Website Address renewal date: 16/10/11
  • Domain Address Reg. date: 09/10/15
  • Website address in use until: 17/10/15
MS LifeLines | Support for Relapsing MS
http://site-overview.com/stats/mslifelines.com
MS LifeLines offers support for those living with relapsing MS. Learn more about symptoms and a support community.
  • Website Address renewal date: 16/11/8
  • Domain Address Reg. date: 02/2/11
  • Website address in use until: 18/2/11
Treatment for Asthma in Children | PULMICORT RESPULES® (budesonide inhalation suspension)
http://site-overview.com/stats/pulmicortrespules.com
  • Website Address renewal date: 17/2/24
  • Domain Address Reg. date: 99/2/28
  • Website address in use until: 18/2/28
Physiodesk
http://site-overview.com/stats/physiodesk.com
Physiodesk is started with a vision to give best IT Solutions to Physiotherapist of India and abroad. Our Aim is to establish Quality Care Physiotherapy to general patients which we believe can be achieved with proper administration, supervision and documentation.Our Aim is to provide Software useful in physiotherapy field not only for proper record keeping but also for the betterment in treatment procedure. The software will offer professional advice, not only to the clinician, but to anyone in the market in the field of physiotherapy.We offer a prompt and efficient service and are committed to providing all your needs in the area of natural healing therapies for physiotherapists.
  • Google+ Identity: +physiodeskinfo
  • Website Address renewal date: 15/12/22
  • Domain Address Reg. date: 15/5/20
  • Website address in use until: 18/5/20
Ibogaine: A Bwiti Based Pharmacology & Plant Master Teacher - Website of Lee Albert
http://site-overview.com/stats/myeboga.com
Ibogaine, Eboga, Iboga, Addiction, Dependence, Treatment, Providers, Audiovisual, Healing, Books, Media, Experiences, Articles, Fatalities, Forms, History, Bwiti, Cure, Articles, News, Administration, Supply, Safety.
  • Google Analytics ID: 77446339-1
  • Website Address renewal date: 18/1/10
  • Domain Address Reg. date: 03/6/3
  • Website address in use until: 19/6/3
Recipes, Activities, Treatment and Support for your Health Conditions
http://site-overview.com/stats/fit2me.com
Fit2Me™ a FREE food and activity program that's custom fit to you and your health challenges. Plus, there's personalized treatment information and support!
  • Website Address renewal date: 16/8/11
  • Domain Address Reg. date: 11/8/15
  • Website address in use until: 17/8/15
MOVANTIK® (naloxegol) | Opioid Induced Constipation Treatment
http://site-overview.com/stats/movantik.com
Official Web site for MOVANTIK® (naloxegol) tablets, for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.
  • Website Address renewal date: 16/9/20
  • Domain Address Reg. date: 13/9/25
  • Website address in use until: 17/9/25
Melasma Treatment & Skin Care | Tri-Luma® Cream (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%)
http://site-overview.com/stats/triluma.com
Tri-Luma<sup>®</sup> Cream is clinically proven in effectively treating moderate to severe melasma.
  • Google Analytics ID: 22693964-4
  • Website Address renewal date: 16/12/13
  • Domain Address Reg. date: 99/11/30
  • Website address in use until: 19/11/30
Home
http://site-overview.com/stats/kcepc.com
Since our founding in 1983, KC Engineering and Land Surveying, P.C. (KC) has kept pace with the rapidly changing technological advancements in the industry. We are able to provide our public and private sector clients with a comprehensive range of professional services. The corporate headquarters of the firm is located in New York City with regional offices in Circleville and Poughkeepsie, New York and Denville, New Jersey. KC is a certified Disadvantaged, Small, and Minority Business Enterprise (D/S/MBE). KC offers comprehensive engineering and surveying services, including civil engineering, structural engineering, municipal engineering, land development, construction inspection, construction claims and engineering audits, grant administration, water supply, wastewater treatment, land surveying, and all related services. The KC organization is committed to providing exceptional and personalized service to each client on every project, and we can do it efficiently, effectively, and within budget.
  • Google Analytics ID: 97988624-1
  • Website Address renewal date: 15/4/18
  • Domain Address Reg. date: 02/4/8
  • Website address in use until: 20/4/8
Utility Services of Alaska, Inc. - Your water company - Administration and operations for Golden Heart Utilities and College Utilities Corporation
http://site-overview.com/stats/akwater.com
Utility Services Alaska provides administration and customer service for Golden Heart and College Utilities in Fairbanks Alaska. Operations include water and wastewater treatment, water distribution and wastewater collections, and compost from biosolids.
  • Website Address renewal date: 15/2/12
  • Domain Address Reg. date: 98/3/11
  • Website address in use until: 18/3/10
Home
http://site-overview.com/stats/cphengineers.com
CPH is a full service architecture and engineering and has the capabilities to provide: architecture, engineering (site, utility, traffic/transportation, MEP, structural), planning, landscape architecture, surveying, environmental science, and construction administration.
  • Website Address renewal date: 17/12/21
  • Domain Address Reg. date: 98/1/19
  • Website address in use until: 21/1/18
Mesothelioma Cancer Information - Treatment Options and Prognosis
http://site-overview.com/stats/mesotheliomahelp.org
Mesothelioma Help aims to offer support for families with valuable information and resources about this malignant asbestos cancer.
  • Google+ Identity: 105170876158287022541
  • Google Analytics ID: 43913755-1
  • Website Address renewal date: 16/12/13
  • Domain Address Reg. date: 06/12/12
  • Website address in use until: 17/12/12
Welcome | Coastal Engineering Co.
http://site-overview.com/stats/coastalengineeringcompany.com
Professional engineering and land surveying firm serving Cape Cod, The Islands, and Southern New England.
  • Google+ Identity: 104263955620459223815
  • Google Analytics ID: 36900220-1
  • Website Address renewal date: 16/4/7
  • Domain Address Reg. date: 05/6/6
  • Website address in use until: 21/6/6
FARXIGA® (dapagliflozin) | Treatment for Type 2 Diabetes Mellitus in Adults
http://site-overview.com/stats/farxiga-hcp.com
FARXIGA® (dapagliflozin) is an SGLT2 inhibitor indicated for patients with type 2 diabetes mellitus. Explore the science behind FARXIGA.
  • Website Address renewal date: 16/9/19
  • Domain Address Reg. date: 13/9/23
  • Website address in use until: 17/9/23
TNKase® Acute Myocardial Infarction Treatment
http://site-overview.com/stats/tnkase.com
Learn more about single-bolus TNKase® (tenecteplase) acute myocardial infarction treatment and the 5-second TNKase® dosing and administration. Indication For use in mortality reduction associated with acute myocardial infarction (AMI). Treatment should be initiated as soon as possible after the onset of AMI symptoms. Important Safety Information TNKase therapy in patients with acute myocardial infarction is contraindicated in the following certain situations (eg, active internal bleeding, history of cerebrovascular accident, known bleeding diathesis, severe uncontrolled hypertension) because of an increased risk of bleeding [See CONTRAINDICATIONS in full prescribing information]. The most common complication encountered during TNKase therapy is bleeding. Should serious bleeding (not controlled by local pressure) occur, any concomitant heparin or antiplatelet agents should be discontinued immediately. In certain conditions (eg, recent major surgery, cerebrovascular disease, hypertension) the risk of TNKase therapy may be increased and should be weighed against the anticipated benefits. [See WARNINGS in full prescribing information]. Cholesterol embolism has been reported rarely in patients treated with all types of thrombolytic agents; the true incidence is unknown. Coronary thrombolysis may result in arrhythmias associated with reperfusion. It is recommended that anti-arrhythmic therapy for bradycardia and/or ventricular irritability be available when TNKase is administered. Please see full Prescribing Information for additional important safety information.
  • Website Address renewal date: 16/10/24
  • Domain Address Reg. date: 00/3/13
  • Website address in use until: 18/3/13
- Pure Love For Pets - English
http://site-overview.com/stats/pureloveforpets.com
  • Known AddThis user account: ra-51798fa60b850da9
  • Website Address renewal date: 17/2/22
  • Domain Address Reg. date: 10/3/24
  • Website address in use until: 18/3/24
Electronic Medical Record-EMR | Electronic Health Record Software - Optimus EMR, Inc
http://site-overview.com/stats/optimusemr.com
Optimus EMR provides industry-leading Electronic Medical Record (EMR) and Electronic Health Record (EHR) software for long term care, nursing home, skilled nursing, and post acute care facilities.
  • Google Analytics ID: 12160578-1
  • Website Address renewal date: 16/7/11
  • Domain Address Reg. date: 06/3/14
  • Website address in use until: 20/3/14
Inducing Remission in GPA & MPA Patients | Rituxan® GPA & MPA | HCP
http://site-overview.com/stats/rituxanforgpampa-hcp.com
Find information for healthcare professionals about Rituxan® (rituximab), the only FDA-approved treatment proven to induce remission in patients with GPA and MPA. INDICATION STATEMENT - Rituxan® (rituximab), in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) - Limitations of Use: Rituxan is not recommended for use in patients with severe, active infections BOXED WARNINGS and Additional Important Safety Information BOXED WARNINGS Infusion Reactions: Rituxan administration can result in serious, including fatal, infusion reactions. Deaths within 24 hours of Rituxan infusion have occurred. Approximately 80% of fatal infusion reactions occurred in association with the first infusion. Monitor patients closely. Discontinue Rituxan infusion for severe reactions and provide medical treatment for Grade 3 or 4 infusion reactions. Severe Mucocutaneous Reactions: Severe, including fatal, mucocutaneous reactions can occur in patients receiving Rituxan. Hepatitis B Virus (HBV) Reactivation: HBV reactivation can occur in patients treated with Rituxan, in some cases resulting in fulminant hepatitis, hepatic failure, and death. Screen all patients for HBV infection before treatment initiation, and monitor patients during and after treatment with Rituxan. Discontinue Rituxan and concomitant medications in the event of HBV reactivation. Progressive Multifocal Leukoencephalopathy (PML): PML, including fatal PML, can occur in patients receiving Rituxan. Warnings and Precautions Rituxan administration can also result in additional serious, including fatal, adverse reactions including: - Tumor lysis syndrome (TLS): Administer aggressive intravenous hydration, anti‑hyperuricemic agents, monitor renal function - Infections: Withhold Rituxan and institute appropriate anti-infective therapy - Cardiac arrhythmias and angina: Discontinue infusions in case of serious or life-threatening events - Bowel obstruction and perforation: Consider and evaluate for abdominal pain, vomiting, or related symptoms - Live virus vaccines: Do not administer live virus vaccines prior to or during Rituxan - Cytopenias: Monitor blood counts at regular intervals Granulomatosis With Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) - Use of concomitant immunosuppressants other than corticosteroids has not been studied in GPA or MPA patients exhibiting peripheral B-cell depletion following treatment with Rituxan. Observe patients with GPA and MPA closely for signs of infection if immunosuppressants other than corticosteroids are used concomitantly - The safety and efficacy of retreatment with Rituxan have not been established in patients with GPA and MPA - Common adverse reactions (≥15%) in the clinical study were infections, nausea, diarrhea, headache, muscle spasms, anemia, and peripheral edema. Other important adverse reactions include infusion reactions You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. For additional safety information, please see the Rituxan full prescribing information, including BOXED WARNINGS.
  • Google Analytics ID: 48974804-1
  • Website Address renewal date: 17/12/1
  • Domain Address Reg. date: 13/11/27
  • Website address in use until: 19/11/27
STRABAG International - Worldwide Experience
http://site-overview.com/stats/dywidag.com
Strabag International GmbH is the partner for international construction covering civil engineering, prime building construction and transportation infrastructure.
  • Google Analytics ID: 52811732-9
  • Website Address renewal date: 17/5/22
  • Domain Address Reg. date: 98/5/22
  • Website address in use until: 18/5/21
Home
http://site-overview.com/stats/iressa.com
Official site of IRESSA (gefitinib), indicated in Europe for the treatment of adults with locally advanced or metastatic NSCLC with activating mutations of EGFR-TK across all lines of therapy.
  • Website Address renewal date: 16/8/9
  • Domain Address Reg. date: 99/8/13
  • Website address in use until: 17/8/13
Prescription Rosacea Treatment | METROGEL® (metronidazole) Gel, 1%
http://site-overview.com/stats/metrogel.com
Metrogel is the only prescription rosacea treatment that is effective yet well tolerated, and available in a once-daily, measured-dose pump for consistent delivery.
  • Website Address renewal date: 16/12/15
  • Domain Address Reg. date: 97/7/25
  • Website address in use until: 18/7/24
Psoriasis Treatment – Shampoo, Spray, and Lotion – Clobex® (clobetasol propionate)
http://site-overview.com/stats/clobex.com
Discover Clobex® (clobetasol propionate), a powerful medication available in spray, shampoo, and lotion for the treatment of psoriasis.
  • Google Analytics ID: 10707947-18
  • Website Address renewal date: 16/12/13
  • Domain Address Reg. date: 00/2/22
  • Website address in use until: 19/2/22
Back Pain Treatments & Symptoms | Back Pain Resources
http://site-overview.com/stats/back.com
Find information relating to your back pain symptoms and treatment options. Back.com offers tools and support to help you take the next step.
  • Known AddThis user account: ra-526023a4481e873e
  • Google Analytics ID: 28302736-1
  • Website Address renewal date: 17/4/20
  • Domain Address Reg. date: 97/5/21
  • Website address in use until: 19/5/22
STRABAG International
http://site-overview.com/stats/zueblin-international.com
STRABAG International GmbH is the partner for international construction covering civil engineering, prime building construction and transportation infrastructure.
  • Google Analytics ID: 52811732-9
  • Website Address renewal date: 17/10/17
  • Domain Address Reg. date: 01/10/16
  • Website address in use until: 18/10/16
TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) | HCP Site
http://site-overview.com/stats/tudorzahcp.com
Healthcare professional information on TUDORZA PRESSAIR (aclidinium bromide inhalation powder), an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with COPD.
  • Website Address renewal date: 16/3/24
  • Domain Address Reg. date: 12/5/10
  • Website address in use until: 20/5/10
Ibogaine: A Bwiti Based Pharmacology & Plant Master Teacher - Website of Lee Albert
http://site-overview.com/stats/myeboga.org
Ibogaine, Eboga, Iboga, Addiction, Dependence, Treatment, Providers, Audiovisual, Healing, Books, Media, Experiences, Articles, Fatalities, Forms, History, Bwiti, Cure, Articles, News, Administration, Supply, Safety.
  • Google Analytics ID: 77446339-1
  • Website Address renewal date: 16/9/17
  • Domain Address Reg. date: 03/10/17
  • Website address in use until: 17/10/17
INGREZZA® (valbenazine) for adults with tardive dyskinesia (TD) | HCP Website
http://site-overview.com/stats/ingrezzahcp.com
Get information on INGREZZA safety, dosing, and efficacy to help support your adult patients with TD. See safety and product information.
  • Google Analytics ID: 76386630-4
  • Website Address renewal date: 17/9/12
  • Domain Address Reg. date: 17/9/12
  • Website address in use until: 19/9/12
CytoBioScience ...Where Tomorrow Begins Today
http://site-overview.com/stats/cytocentrics.com
We combine bioscience, nanoscience, microchip development,algorithms and engineering to develop and manufacture instrumentation that supports ion channel research and new approaches to disease analysis and individualized treatment modalities.
  • Google Analytics ID: 96127652-1
  • Website Address renewal date: 16/8/18
  • Domain Address Reg. date: 01/8/17
  • Website address in use until: 17/8/17
Rebif® (interferon beta-1a) for Relapsing MS
http://site-overview.com/stats/rebif.com
Official site of Rebif® (interferon beta-1a). Find information on Rebif, financial assistance, treatment and support.
  • Website Address renewal date: 16/11/16
  • Domain Address Reg. date: 01/6/11
  • Website address in use until: 18/6/11
Conway Homer is America’s most experienced vaccine injury law firm
http://site-overview.com/stats/ccandh.com
Conway Homer, P.C. is the nations most experienced Vaccine Injury Law Firm. Representing clients from all 50 states, our attorneys specialize in the NVICP.
  • Known AddThis user account: ra-558ac14e7f79bff7
  • Google Analytics ID: 106445098-1
  • Website Address renewal date: 17/10/7
  • Domain Address Reg. date: 97/10/23
  • Website address in use until: 18/10/22
Renal Denervation - Hypertension Device-Based Approaches | Medtronic
http://site-overview.com/stats/medtronicrdn.com
Medtronic RDN is the premiere online resource for renal denervation and treatment-resistant hypertension. Medtronic is committed to finding innovative solutions.
  • Google Analytics ID: 28302736-1
  • Website Address renewal date: 16/7/22
  • Domain Address Reg. date: 11/8/23
  • Website address in use until: 18/8/23
2024-06-04 14:47:51 ... 0.0758